Evidence map›Paper›PMID 42516575›Full record

ArticleBio-protocol2026

An Accurate and Precise ddPCR-Based Method for Determining the Concentration of Plasmid DNA.

Franco Puleo, Annicka Evans, Cullen Mason

Abstract read
In one paragraph

Article in Bio-protocol, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Franco PuleoTechnical Development, Biogen, Cambridge, MA, USA.
Annicka EvansTechnical Development, Biogen, Cambridge, MA, USA.
Cullen MasonTechnical Development, Biogen, Cambridge, MA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transient transfection is commonly used for the commercial production of adeno-associated viral particles for gene therapy. In this process, packaging cells such as HEK293 cells are transfected with three plasmids, including the Rep/Cap plasmid, the Helper plasmid, and the gene-of-interest plasmid containing the transgene/gene therapy product. The combination of these plasmids allows for the robust production of recombinant adeno-associated viral particles. As a result, the concentration of these plasmids plays a critical role in viral production and must be accurately assessed. Typically, A

Indexed as

DNA linearizationDroplet digital PCRGene therapy workflowsPlasmid DNAProcess developmentrAAV manufacturingSelection cassette targeting

Identifiers

PMID42516575
PMCPMC13403130

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.